InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 32,750
+250 (0.77%)
At close: Dec 30, 2025
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 399.3 billion as of December 30, 2025. Its market cap has increased by 39.94% in one year.
Market Cap
399.30B
Enterprise Value
309.32B
Revenue
226.62B
Ranking
n/a
PE Ratio
12.47
Stock Price
32,750.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 399.30B, an increase of 3,666.24%. That is a compound annual growth rate of 18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 399.30B | 34.21% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 24.33T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.45T |